1.11 USD
↘ 0.33 (22.90%)AT CLOSE (03:59 PM EDT)
60 Degrees Pharmaceuticals, Inc. Common Stock
SXTPNASDAQ • USD
1.05
↘ 0.06 (5.41%)
POST MARKET (AS OF 06:04 PM EDT)
Post Market
AS OF 06:04 PM EDT
1.05
↘ 0.06 (5.41%)
Market: OPEN
Shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) are trading at $1.05. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place SXTP at a fair price relative to peers.
Technical & fundamental data as of Oct 6, 2026.
Open?$1.07
High?$1.20
Low?$0.89
Prev. Close?$1.44
Volume?2.4M
Avg. Volume?96.8K
VWAP?$1.32
Rel. Volume?25.19x
Bid / Ask
Bid?$0.92 × 100
Ask?$1.33 × 100
Spread?$0.41
Midpoint?$1.13
Valuation & Ratios
Market Cap?5.1M
Shares Out?3.5M
Float?1.9M
Float %?73.0%
P/E Ratio?N/A
P/B Ratio?1.94
EPS?-$2.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Employees
3
Market Cap
5.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-12
Address
1025 CONNECTICUT AVENUE NW
WASHINGTON, DC 20036
Phone: 202-327-5422
WASHINGTON, DC 20036
Phone: 202-327-5422
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?50
Short Sent.?76
Piotroski F-Score?1/9Weak
Altman Z-Score?-21.10Distress
Confidence?48%Low
Short InterestHigh
Short % of Float?11.13%High
Short Interest?216.0K
Days to Cover?3.0
Free Float1.9M
Avg Daily Volume72.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.32Strong
Quick Ratio?1.78Adequate
Cash Ratio?0.64Adequate
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?1.94CHEAP▾
Peers100
S&P75
P/S?4.17FAIR▾
Peers100
S&P36
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?3.45FAIR▾
Peers100
S&P54
Returns & Efficiency
ROE?-329.6%WEAK▾
S&P3
ROA?-201.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-8894688
Enterprise Value?$4.2M
Fundamentals ratios updated end of day